Dr. Mehdi M. Moezi, MD

  • Jacksonville, FL
  • Hematologist and oncologist
NPI1053316190PAC ID4688625221
Medicare services, 2024
106,268
Medicare patients, 2024
949
Part D claims, 2024
1,166
Publications
5
Clinical trials
6
Practice address
7015 A C Skinner Pkwy, Jacksonville, FL 32256
Practice phone
Call (904) 363-2113
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Cancer Specialists of North Florida

Jacksonville, Florida

See all 7 affiliations

Find Dr. Moezi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mehdi M. Moezi is a hematologist and oncologist in Jacksonville, Florida

Dr. Moezi practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Moezi's NPI, 1053316190, was assigned on June 16, 2005. Dr. Moezi graduated from Tehran University of Medical Sciences School of Medicine in 1990. Dr. Moezi holds Florida license ME80061.

NPI and contact details
Medicare PAC ID
4688625221
NPI enumeration date
June 16, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(904) 363-2113
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
62
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mehdi M. Moezi practices at Cancer Specialists of North Florida in Jacksonville, Florida

Dr. Moezi's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

  • Cancer Specialists of North Florida
    7015 A C Skinner Pkwy, Jacksonville, FL 32256 · Duval CountyPhone(904) 363-2113

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Mehdi M. Moezi is affiliated with 6 sites of care and 1 medical group

Dr. Moezi's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Moezi is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Moezi to 3 more hospitals and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Moezi

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mehdi M. Moezi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moezi practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Cancer Specialists of North FloridaAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Moezi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mehdi M. Moezi is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Moezi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Moezi is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Moezi's licenses on file in 3 states: Florida, California and Utah.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME80061 · 2000 to 2026 · taxonomy 207RH0003X
  • California licenseSince 2005
  • Utah license1998 to 2006

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Moezi treats.

Hematologists and oncologists near Dr. Moezi

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mehdi M. Moezi billed Medicare for 106,268 services in 2024

CMS data shows 106,268 Medicare services from Dr. Moezi across 50 procedure codes in 2024, for 949 Medicare patients. Medicare paid $895,652 for them.

Medicare services, 2024106,268
Medicare patients949
Paid by Medicare$895,652
Procedure codes50

Dr. Moezi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Other services
2023: 43,0722024: 50,89318%
Drugs given in the office
2023: 51,3832024: 48,6135%
Imaging
2023: 1,4462024: 1,65514%
Lab and pathology
2023: 1,7442024: 1,6396%
Surgery
2023: 1,5132024: 1,31813%
Tests and treatments
2023: 1,6302024: 1,23824%
Office and hospital visits
2023: 9842024: 9127%

Where Dr. Moezi's Medicare services took place, 2024

  • In an office106,221100%
  • In a facility470%

Dr. Moezi compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Moezi
  • Florida median
Medicare services
106,268vs 697152.5 times
Medicare patients
949vs 2184.4 times
Part D claims
927vs 3412.7 times

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Moezi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Moezi

Need commercial claims for Dr. Moezi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Moezi and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mehdi M. Moezi treated 949 Medicare patients in 2024, average age 75

CMS counts 949 Medicare patients who saw Dr. Moezi in 2024. The largest group is 65 to 74, with 406 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moezi's median patient age at 70, with 58% women.

Medicare patients, 2024949
Average age75
Average risk score1.99
Also on Medicaid6%

Dr. Moezi's Medicare patients by age, 2024

Dr. Moezi's Medicare patients by sex, 2024

  • Women53056%
  • Men41944%

Chronic conditions among Dr. Moezi's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis52%
  4. Cancer48%
  5. Ischemic heart disease45%
  6. Chronic kidney disease39%
  7. Diabetes39%
  8. COPD33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Moezi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women58%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mehdi M. Moezi wrote 1,166 Medicare Part D claims in 2024

In 2024, Dr. Moezi wrote 1,166 Medicare Part D claims for 192 patients. 73% of them were for generic drugs. CMS names the drug for 927 of them, across 36 drugs with 11 or more claims each, at $1,871,820 in total drug cost. In 2023, CMS named 734 claims across 27 drugs.

Part D claims, 20241,166
Drugs named by CMS36
Total drug cost$1.9M
Part D patients192

Dr. Moezi's Part D claims by kind of drug, 2024

  • Generic846 claims73%
  • Brand-name320 claims27%

Dr. Moezi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Moezi's Part D claims, 2024

  • Opioids8%98 of 1,166 claims
  • Antibiotics5%55 of 1,166 claims
  • Antipsychotics, patients 65 and over1%11 of 1,166 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7342024: 92726%

Drugs named by CMS: 36 in 2024, 27 in 2023.

See all prescribing by Dr. Moezi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Mehdi M. Moezi takes part in Medicare

Dr. Moezi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Moezi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mehdi M. Moezi has 5 publications on record

Dmand AI links 5 papers to Dr. Moezi, published from 2012 to 2024. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Carboplatin and Etoposide. Dr. Moezi's most frequent co-authors are Helen J. Ross, MD, Marshall T. Schreeder, MD and Laura Johnetta Blakely, MD.

Papers5
Years published2012 to 2024

Dr. Moezi's papers by year, 2012 to 2024

Topics Dr. Moezi writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Carboplatin
  • Etoposide
  • Indoles
  • Lung Neoplasms
  • Pyrroles
  • Small Cell Lung Carcinoma

Dr. Moezi's most frequent co-authors

Recent publications by Dr. Moezi

See all 5 publications and co-authors

See who Dr. Moezi researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Moezi works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mehdi M. Moezi has worked on 6 clinical trials

Dmand AI links Dr. Moezi to 6 clinical trials, 5 of them phase 3 studies. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Anemia, Refractory, with Excess of Blasts. Bristol-Myers Squibb sponsors the most, 2.

Clinical trials with Dr. Moezi by phase

  1. NonePhase 1: no trials
  2. 1Phase 2: 1 trial
  3. 5Phase 3: 5 trials
  4. NonePhase 4: no trials

Conditions in Dr. Moezi's trials

  • Multiple Myeloma
  • Blood Protein Disorders
  • Anemia, Refractory, with Excess of Blasts
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Follicular

Investigators on the most trials with Dr. Moezi

Recent clinical trials with Dr. Moezi

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Mehdi M. Moezi received $157,916 in industry payments from 2016 to 2025

CMS Open Payments shows 534 general payments to Dr. Moezi from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Bristol-Myers Squibb Company paid the most, $49,304. It also lists 4 research payments totaling $7,670 from 2022 to 2024.

General payments to Dr. Moezi by program year, 2016 to 2025

General payments to Dr. Moezi by kind, 2016 to 2025

$157.9Kin total
  • Speaker and faculty fees$68,60043%
  • Consulting fees$49,89732%
  • Travel and lodging$29,45619%
  • Food and beverage$9,4346%
  • Education$5290%

Companies that paid Dr. Moezi the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Moezi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mehdi M. Moezi has 1 award and honors on record

Dmand AI lists 1 award for Dr. Moezi, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Moezi

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Mehdi M. Moezi graduated from Tehran University of Medical Sciences School of Medicine

Dr. Moezi graduated from Tehran University of Medical Sciences School of Medicine in 1990. Dr. Moezi is a member of ACP, AMA, ASCO, ASH and European Society of Medical Oncology.

  1. Medical schoolTehran University of Medical Sciences School of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Mehdi M. Moezi accepts plans from 18 insurance carriers

Dr. Moezi is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Aetna
  • United Healthcare
  • Elevance
  • HCSC
  • Humana
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • Blue Cross Blue Shield of Michigan
  • +10 more carriersWith a free account

Plan types Dr. Moezi accepts, by number of carriers

  1. PPO11
  2. HMO8
  3. Medicare7
  4. EPO4
  5. POS3
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Mehdi M. Moezi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mehdi M. Moezi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mehdi M. Moezi's NPI number?

Dr. Mehdi M. Moezi's NPI number is 1053316190. It was assigned on June 16, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Mehdi M. Moezi?

Dr. Mehdi M. Moezi is a hematologist and oncologist in Jacksonville, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Mehdi M. Moezi practice?

Dr. Moezi practices at 7015 A C Skinner Pkwy, Jacksonville, FL 32256. Dr. Moezi's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dmand AI also links Dr. Moezi to 3 hospitals and 1 group practice or clinic.

What is Dr. Mehdi M. Moezi's office phone number?

The practice phone on file for Dr. Moezi is (904) 363-2113.

What is Dr. Mehdi M. Moezi's medical license number?

Dr. Moezi holds Florida license ME80061, one of the licenses on file in 3 states.

Which states has Dr. Mehdi M. Moezi been licensed in?

Dmand AI has state licenses on file for Dr. Moezi in Florida (2000 to 2026), California (since 2005) and Utah (1998 to 2006).

Which hospitals is Dr. Mehdi M. Moezi affiliated with?

Dr. Moezi is affiliated with Baptist Medical Center Jacksonville. Dmand AI links Dr. Moezi to 3 more hospitals.

What medical group is Dr. Mehdi M. Moezi part of?

Dr. Moezi is linked to Cancer Specialists of North Florida.

Does Dr. Mehdi M. Moezi accept Medicare?

Yes. CMS data shows Dr. Moezi billed Medicare for 106,268 services in 2024, and Dr. Moezi accepts Medicare assignment.

How many Medicare patients does Dr. Mehdi M. Moezi see?

CMS counts 949 Medicare patients who saw Dr. Moezi in 2024, with an average age of 75.

Show 9 more questionsShow fewer questions

Is Dr. Mehdi M. Moezi board certified?

Yes. Dr. Moezi is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Mehdi M. Moezi bill to Medicare?

In 2024, Dr. Moezi's most billed Medicare services were medicare temporary code (Q9967), injected or infused drug (J1439) and medical supplies or transport (A9575).

Where did Dr. Mehdi M. Moezi go to medical school?

Dr. Moezi graduated from Tehran University of Medical Sciences School of Medicine in 1990.

What drugs does Dr. Mehdi M. Moezi prescribe most?

In 2024 Medicare Part D data, Dr. Moezi's most prescribed drugs by claims were Letrozole, Eliquis and Ibandronate Sodium.

Has Dr. Mehdi M. Moezi received payments from drug or device companies?

CMS Open Payments shows $157,916 in general payments to Dr. Moezi from 56 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Mehdi M. Moezi been practicing?

Dr. Moezi graduated from medical school in 1990, 36 years ago.

Does Dr. Mehdi M. Moezi do research?

Dmand AI links 5 publications to Dr. Moezi, published from 2012 to 2024. Dr. Moezi has worked on 6 clinical trials.

Who does Dr. Mehdi M. Moezi publish with?

Dr. Moezi's most frequent co-authors are Helen J. Ross, MD (2 shared papers), Marshall T. Schreeder, MD (2 shared papers) and Laura Johnetta Blakely, MD (1 shared paper).

What insurance does Dr. Mehdi M. Moezi accept?

Dr. Moezi is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)